🇺🇸 Evolocumab or Alirocumab in United States

Evolocumab or Alirocumab (Evolocumab or Alirocumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Evolocumab or Alirocumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Evolocumab or Alirocumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Evolocumab or Alirocumab in United States?

Rigshospitalet, Denmark is the originator. The local marketing authorisation holder may differ — check the official source linked above.